Protalix Biotherapeutics Inc (PLX.A)

PLX.A on American Stock Exchange

2.14USD
6 May 2015
Change (% chg)

$0.03 (+1.42%)
Prev Close
$2.11
Open
$2.10
Day's High
$2.17
Day's Low
$2.10
Volume
25,501
Avg. Vol
28,475
52-wk High
$4.20
52-wk Low
$1.59

PLX.A

Chart for PLX.A

About

Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant... (more)

Overall

Beta: 1.16
Market Cap(Mil.): ₪794.57
Shares Outstanding(Mil.): 93.60
Dividend: --
Yield (%): --

Financials

  PLX.A Industry Sector
P/E (TTM): -- 188.47 40.23
EPS (TTM): -1.24 -- --
ROI: -43.12 -0.64 15.26
ROE: -- -2.50 16.08
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks